Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving ...

A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and neck squamous cell ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

The strong results of KEYNOTE-689 and likely FDA approval of pembrolizumab for perioperative HNSCC raise both concerns and ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration," published in the April 2025 issue of ...

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...

The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk ...